Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
---|---|---|---|---|---|
William Tai-Wei Ho | PRESIDENT AND CEO, Director, 10%+ Owner | $2.42M | Apr 27, 2025 | ||
Leslie W. Kreis | 10%+ Owner | $1.29M | May 2, 2025 | ||
Aaron G.L. Fletcher | 10%+ Owner | $1.29M | May 2, 2025 | ||
Peter C. Brandt | Director | $141K | May 8, 2025 | ||
Alan S. Roemer | Director | $73.5K | May 8, 2025 | ||
Patrick McCall | Chief Financial Officer | $12.4K | Apr 27, 2025 | ||
Kate Rochlin | Chief Operating Officer | $10.2K | Apr 27, 2025 | ||
Trishna Goswami | Chief Medical Officer | $6.39K | Sep 4, 2024 | ||
Emily Fairbairn | Director | May 8, 2025 | |||
Jeremy R. Graff | Director | May 8, 2025 | |||
Luba Greenwood | Director | May 8, 2025 | |||
Lawrence Lamb | EVP and CSO | Apr 27, 2025 | |||
Melissa Beelen | VP, Clinical Operation | Jul 29, 2021 | |||
Bios Equity Partners, LP | 10%+ Owner | Aug 13, 2021 | |||
Bios Clinical Opportunity Fund, LP | 10%+ Owner | Dec 13, 2023 | |||
Corinne Epperly | Director | May 8, 2025 | |||
Travis Whitfill | Director | Dec 19, 2024 |
Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
---|